CEA-Leti receives $1.3M to support fluorescent imaging agent

07/8/2013 | BioOptics World

Bpifrance's Strategic Industrial Innovation program awarded CEA-Leti $1.3 million to support the preclinical development of fluorescent imaging agent LipImage 815. The imaging agent delivers a fluorescent substance via lipid nanoparticles to detect liver cancer cells in the early stages of the disease.

View Full Article in:

BioOptics World

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA